Director, President and CEO · EXAGEN INC. · Common Stock
Side
SELL
Value
$270K
Shares
34.3K
Price
$7.87
Executed
Oct 16, 2026
Disclosed
Oct 19, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Oct 16 executedOct 19, 2026 disclosed
XGN · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Other disclosed activity · XGN
No records
No other disclosures for this security in the dataset.
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
Aballi John filed this Form 4 reporting a open-market sale of XGN on Oct 16, 2026. It became public on Oct 19, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President and CEO
Aballi Johncik:0001843113
Issuer
EXAGEN INC.cik:0001274737
Revision history · 0
No field has changed since this record was first ingested.
